John James O'Connor - Feb 28, 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Director
Signature
/s/ Nathan Ulrich
Stock symbol
LMAT
Transactions as of
Feb 28, 2025
Transactions value $
$0
Form type
4
Date filed
3/4/2025, 07:23 PM
Previous filing
Dec 13, 2024
Next filing
Mar 31, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Award $0 +204 +0.36% $0.00 57.3K Feb 28, 2025 Direct F1, F2
transaction LMAT Common Stock Options Exercise $0 +1 +0% $0.00 57.3K Feb 28, 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -1 -24.94% $0.00 3.01 Feb 28, 2025 Common Stock 1 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent LMAT common stock acquired on February 28, 2025, upon settlement of a Performance Share Unit (PSU) award granted on December 8, 2023. The PSU award vests as follows: 1/3 upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next two years.
F2 Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals.
F3 Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F4 These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.